Home
>
US Stocks
>
Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
ARWR

Arrowhead Pharmaceuticals Inc.

$66.794.1%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
66.48
Today Low/High
65.59 / 67.01
52 Week Low/High
$32.86 / $93.66
P/E ratio
-50.2389
Market Cap
$6.33B

Company Details

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing.
Organisation
Arrowhead Pharmaceuticals Inc.
Headquaters
Pasadena, California, US
Employees
232
Industry
Health Technology
CEO
Christopher Anzalone

Discover more

Frequently Asked Questions

What is Arrowhead Pharmaceuticals Inc. share price today

Can Indians buy Arrowhead Pharmaceuticals Inc. shares?

How can I buy Arrowhead Pharmaceuticals Inc. shares from India?

Can Fractional shares of Arrowhead Pharmaceuticals Inc. be purchased?

What are the documents required to start investing in Arrowhead Pharmaceuticals Inc. stocks?

We are a SEBI registered investement advisor